Skip to content

Effect of Probiotic on Oral health- a Randomized controlled trial.

CLINICAL AND MICROBIOLOGICAL EFFECT OF PROBIOTIC ON ORAL HEALTH- A RANDOMIZED CONTROLLED TRIAL.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/12/022372
Enrollment
30
Registered
2019-12-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: enkor instamelt: 1gm sachet, contains streptococcus salivarius and lactobacillus specie. Control Intervention1: non sugar milk powder: no relavent details.

Sponsors

BADE JYOSNA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Systemically healthy individuals with moderate gingivitis Subjects having at least 20 natural teeth. Who will be ready to follow and take the regimen as instructed during study period.

Exclusion criteria

Exclusion criteria: 1. having orthodontic appliances, RPD, FPD. 2. Patients with a history of periodontal surgery during the previous three months from the day of examination. 3. Subjects under any other form of probiotic products. 4. Pregnant or lactating females will be excluded. 5. Subjects under anti-inflammatory medication or antibiotic past four weeks to the study. 6. Subjects with systemic diseases. 7. Subjects with malaligned teeth. 8. Prescribed medication with a known effect on gingival growth. 9. Subjects with carious lesions, fluorosis. 10. Using commercially available mouth rinse and having smoking habit. 11. Subjects with non-plaque induced gingivitis.

Design outcomes

Primary

MeasureTime frame
gingival status- Loe and Sillness gingival index, plaque status- Turesky-Gilmore-Glickman plaque index, CFU of streptococcus - CRT bacteria test. Timepoint: 1st day (baseline), 7th day, 21st day and 49th day.

Secondary

MeasureTime frame
plaque status- turesky-gilmore-glickman modification of quigley hein plaque index.Timepoint: baseline, day 7, day 21 and after 4weeks.

Countries

India

Contacts

Public ContactBADE JYOSNA

NTR university of health sciences

Dr.chandu@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026